Holen Sie sich die Stockscreener-App
3.20
1.27%
0.04
Schlusskurs vom Vortag:
$3.16
Offen:
$3.17
24-Stunden-Volumen:
59,400
Relative Volume:
0.12
Marktkapitalisierung:
$122.60M
Einnahmen:
$2.76M
Nettoeinkommen (Verlust:
$-49.12M
KGV:
-2.1333
EPS:
-1.5
Netto-Cashflow:
$-46.21M
1W Leistung:
+9.59%
1M Leistung:
+6.31%
6M Leistung:
-37.98%
1J Leistung:
-59.90%
1-Tages-Spanne:
$3.12
$3.21
1-Wochen-Bereich:
$2.90
$3.24
52-Wochen-Spanne:
$2.37
$8.30
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
Firmenname
Orchestra Biomed Holdings Inc
Sektor
Branche
Telefon
646-343-9298
Adresse
150 UNION SQUARE DRIVE, NEW HOPE
Vergleichen Sie OBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
3.20 | 111.87M | 2.76M | -49.12M | -46.21M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-20 | Eingeleitet | BTIG Research | Buy |
| 2025-01-02 | Eingeleitet | Barclays | Overweight |
| 2024-08-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-07-25 | Eingeleitet | B. Riley Securities | Buy |
| 2024-01-19 | Eingeleitet | Jefferies | Buy |
| 2023-02-24 | Eingeleitet | Piper Sandler | Overweight |
| 2023-02-07 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Orchestra Biomed Holdings Inc Aktie (OBIO) Neueste Nachrichten
Is Orchestra BioMed Holdings Inc. a good long term investmentOver 200% growth - Autocar Professional
What drives Orchestra BioMed Holdings Inc. stock priceRapid-fire capital growth - Autocar Professional
Orchestra BioMed Holdings Inc. Stock Analysis and ForecastBreakthrough stock performance - Autocar Professional
What analysts say about Orchestra BioMed Holdings Inc. stockRapid market gains - jammulinksnews.com
Why Orchestra BioMed Holdings Inc. stock attracts strong analyst attentionFree Predictions - Newser
How Orchestra BioMed Holdings Inc. stock performs during market volatilityDouble Your Capital Alerts - Newser
What makes Orchestra BioMed Holdings Inc. stock price move sharplyMinimized Risk Trading Plan - Newser
How To Trade (OBIO) - news.stocktradersdaily.com
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Consensus Rating of “Buy” by Brokerages - Defense World
Orchestra BioMed (NASDAQ:OBIO) Trading Up 1.7% – Here’s What Happened - Defense World
Orchestra BioMed Secures FDA Clearance for Virtue Trial to Advance Coronary ISR Treatment - MSN
Orchestra BioMed to Present at Jefferies Global Healthcare Conference - MSN
Hedge funds owners may take dramatic actions as Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) recent 14% drop adds to one-year losses - simplywall.st
Learn to Evaluate (OBIO) using the Charts - news.stocktradersdaily.com
Orchestra BioMed: A Contrarian Gem in the Biotech Doldrums - AInvest
Orchestra BioMed Holdings, Inc.(NasdaqGM:OBIO) dropped from Russell Small Cap Comp Value Index - MarketScreener
Orchestra BioMed Confirms Director Elections and Auditor - TipRanks
Orchestra BioMed Showcases AVIM Therapy as Purpose-Built - GlobeNewswire
Millennium Management LLC Makes New Investment in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Citadel Advisors LLC Sells 7,836 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
(OBIO) Trading Advice - news.stocktradersdaily.com
Orchestra Biomed Reports Increased Losses Amid Revenue Growth - TipRanks
B. Riley Cuts Price Target on Orchestra BioMed Holdings to $12 From $15, Keeps Buy Rating - marketscreener.com
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Stake Increased by Northern Trust Corp - Defense World
Orchestra BioMed: Two Best-In-Class Devices And Promising Partnerships - Seeking Alpha
Orchestra BioMed Reports Q1 2025 Financial Results and Advances Key Clinical Programs - MSN
The Manufacturers Life Insurance Company Raises Position in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
FY2026 Earnings Estimate for OBIO Issued By Chardan Capital - Defense World
Orchestra BioMed Expands Patent Portfolio for AVIM Therapy, Gains FDA Breakthrough Designation - MSN
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Tops Revenue Estimates - MSN
Chardan Capital Maintains Buy Rating on OBIO with $20 Price Targ - GuruFocus
Finanzdaten der Orchestra Biomed Holdings Inc-Aktie (OBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):